Shanghai Fosun Pharmaceutical (Group) Co (HK:2196) has released an update.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced the repurchase and cancellation of over 1 million restricted shares, spending a total of RMB 22.83 million. This move comes as a part of their 2022 Restricted A Share Incentive Scheme and follows the resignation of several participants and unmet performance goals. The funds for this transaction will come from the company’s own financial reserves.
For further insights into HK:2196 stock, check out TipRanks’ Stock Analysis page.
